anonymous
Guest
anonymous
Guest
THIS is a healthy take. He/she understands the coin flip15+ years in psych. I accepted the offer and am super excited to give it a go. Sure there are some major risks, but if Caplyta can get the Bp depression indication I think the product has a real shot. If not, the company probably folds or significantly restructures within 2 years. Everyone is in a different place in their career, but for me it’s definitely worth the risk. Good luck everyone.